Skip to content
32

medication

Skip it

A deep review moat (36,041 avg reviews) — this niche doesn't clear our bar today.

Market size 30Growth 21Conversion 24Competition 26Returns 97Price range 45Avg price 59Brand share 9Review moat 8Quality gap 18

Returns

Incredible0.5%

return rate — above 5% kills the launch gate

Avg price

Good$13.08

avg listing price — sweet spot $15–$100

Price range

Okay$3.61–$24.37

cheapest to priciest tracked listing — scored on the share inside $15–$100

Market size

Okay$135K

$135K/yr · 532K searches

Competition

Okay69%

top-5 click share — leaders hold, buyers still browse

Conversion

Bad1.9%

search→purchase rate — share of searches ending in a sale

Growth

Bad-7.9%

90-day search growth — must beat 0% to launch

Quality gap

Bad4.7★

avg incumbent rating — lower means beatable quality

Brand share

Bad96%

top-5 brand share — brand-locked demand

Review moat

Bad36,040.95

avg incumbent reviews — the moat a new listing must climb

Trend